baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BVT Call 220 BIIB 17.05.2024/ DE000VD1GZQ7 /

2024-05-03 8:04:19 PM	Chg.0.000	Bid9:58:11 PM	Ask9:58:11 PM	Underlying	Strike price	Expiration date	Option type
0.300EUR	0.00%	- Bid Size: -	- Ask Size: -	Biogen Inc	220.00 USD	2024-05-17	Call

GlobeNewswire 05-02 Biogen Reports Progress on Corporate Responsibility Priorities

GlobeNewswire 04-29 Muscular Dystrophy Association Launches ALS Awareness Month with Public Service Announcement ‘Answer...

GlobeNewswire 04-25 Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEM...

TeleTrader 04-24 US closes mixed with earnings in limelight

TeleTrader 04-24 Biogen posts Q1 revenue of $2.3 billion

TeleTrader 04-24 US mostly up premarket with earnings in focus

GlobeNewswire 04-23 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...

TeleTrader 04-21 Weekly Preview: Key earnings reports expected

GlobeNewswire 04-17 Unispace Group announces new EMEA CEO appointment

GlobeNewswire 04-15 Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer

GlobeNewswire 04-10 Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer

GlobeNewswire 04-02 ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer

GlobeNewswire 04-02 Avalo Therapeutics Appoints Biotech Leaders to Board of Directors

GlobeNewswire 04-01 Autolus Therapeutics Announces Changes to its Board of Directors

GlobeNewswire 03-25 Dyne Therapeutics Announces CEO Transition

GlobeNewswire 03-13 Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer

GlobeNewswire 03-11 Hyku Biosciences, a Covalent Precision Medicine Company, Announces CEO Transition for its Next Phase...

GlobeNewswire 03-08 From the Beach to the Boardroom: Unispace's 'Art for Impact' Program Partners with NGO to Turn 50,00...

GlobeNewswire 03-07 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Biogen Inc. - BI...

GlobeNewswire 03-06 New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) i...

GlobeNewswire 03-06 Genesis Research Group Announces Appointment of David W. Miller as CEO

GlobeNewswire 03-04 Biogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (...

GlobeNewswire 02-28 Promising Pathways to Simplified Alzheimer's Diagnosis Unveiled in Groundbreaking Study

GlobeNewswire 02-27 Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlig...

GlobeNewswire 02-27 Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024

BVT Call 220 BIIB 17.05.2024/ DE000VD1GZQ7 /

If you wish to receive reply to your feedback, please provide your email address.